Compare Expedia Group Inc (EXPE) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expedia Group Inc vs Illumina, Inc. — how do they compare? Expedia Group Inc trades at $321 (market cap $38.53B), while Illumina, Inc. trades at $193.06 (market cap $29.12B). The key difference: Expedia Group Inc is the larger of the two by market cap, and Expedia Group Inc pays a 0.6% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| EXPE | ILMN | |
|---|---|---|
Market Cap | $38.53B | $29.12B |
Sector | Consumer Cyclical | Health |
52-Week High | $321.07 | $205.10 |
52-Week Low | $188.51 | $91.00 |
Enterprise Value | $37.09B | $30.48B |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Expedia Group Inc
Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
